Skip to main content
. 2016 Nov 29;8(1):1628–1640. doi: 10.18632/oncotarget.13703

Figure 5. Subgroup analysis of the association between PKM2 expression and disease-free survival/ progression-free survival/ recurrence-free survival of solid cancers.

Figure 5